Clinical Trials
Braintumor Website

There are 8 trials:
Facility: Yale University School of Medicine
NCT Trial Name# of Centers

NCT02670083

  CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
212

NCT02484547

  221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
160

NCT02667587

  An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
120

NCT02760602

  A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease
85

NCT02392078

  Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
14

NCT01631552

  Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
12

NCT02273596

  Efficacy and Safety Study of WTX101 in Adult Wilson Disease Patients
11

NCT02017717

  A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
10



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites